2020
IMMU-25. SEVERE AND MULTIFACETED SYSTEMIC IMMUNOSUPPRESSION CAUSED BY EXPERIMENTAL CANCERS OF THE CENTRAL NERVOUS SYSTEM REQUIRES RELEASE OF NON-STEROID SOLUBLE MEDIATORS
Ayasoufi K, Pfaller C, Evgin L, Khadka R, Tritz Z, Goddery E, Fain C, Yokanovich L, Himes B, Jin F, Zheng J, Schuelke M, Hansen M, Tung W, Parney I, Pease L, Vile R, Johnson A. IMMU-25. SEVERE AND MULTIFACETED SYSTEMIC IMMUNOSUPPRESSION CAUSED BY EXPERIMENTAL CANCERS OF THE CENTRAL NERVOUS SYSTEM REQUIRES RELEASE OF NON-STEROID SOLUBLE MEDIATORS. Neuro-Oncology 2020, 22: ii110-ii110. PMCID: PMC7650917, DOI: 10.1093/neuonc/noaa215.455.Peer-Reviewed Original ResearchT-cell countsCD4 T-cell countMHC class II expressionDiffuse intrinsic pontine gliomaClass II expressionThymic involutionT cellsCell countLow CD4 T-cell countsMHC class II expression levelPeripheral T-cell countsSignificant thymic involutionT cell sequestrationAcute neurological insultsCD4 T cellsHallmark featurePeripheral blood monocytesPeripheral T cellsNeurological disease modelsBlood-derived factorsIntrinsic pontine gliomaSystemic immunosuppressionGL261 gliomasBrain insultsCNS cancers
2019
Genomic landscape of de novo stage IV breast cancer.
Garrido-Castro A, Spurr L, Hughes M, Li Y, Cherniack A, Bychkovsky B, Barroso-Sousa R, Di Lascio S, Files J, Kumari P, Cerami E, Krop I, MacConaill L, Lindeman N, Rollins B, Johnson B, Wagle N, Winer E, Dillon D, Lin N. Genomic landscape of de novo stage IV breast cancer. Journal Of Clinical Oncology 2019, 37: 1022-1022. DOI: 10.1200/jco.2019.37.15_suppl.1022.Peer-Reviewed Original ResearchDe novo stage IV breast cancerRecurrent metastatic breast cancerStage IV breast cancerBreast cancerMetastatic tumorsMHC class II expressionMetastatic breast cancerPoor overall survivalClass II expressionFisher's exact testEpithelial-mesenchymal transitionPrimary TNBCCopy number variationsOverall survivalMetastatic sitesCCND1 amplificationImmune escapePotential resistance mechanismsDistinct genomic profilesMetastatic driversMetastatic samplesTreatment selectionExact testMetastatic potentialGenomic profiling
2009
Cutting Edge: Limiting MHC Class II Expression to Dendritic Cells Alters the Ability to Develop Th2- Dependent Allergic Airway Inflammation
Niu N, Laufer T, Homer RJ, Cohn L. Cutting Edge: Limiting MHC Class II Expression to Dendritic Cells Alters the Ability to Develop Th2- Dependent Allergic Airway Inflammation. The Journal Of Immunology 2009, 183: 1523-1527. PMID: 19596982, DOI: 10.4049/jimmunol.0901349.Peer-Reviewed Original ResearchConceptsAllergic airway inflammationMHC class II expressionAirway inflammationDendritic cellsClass II expressionTh2 generationTh2 immunityTh2-dependent allergic airway inflammationTh1 immune responseIFN-gamma productionAirway neutrophiliaTh2 primingRespiratory tractTh2 cellsImmune responseClass II signalsInflammationTh2 recruitmentMice resultsMiceCells altersImmunityActivationCellsNeutrophilia
2004
Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes
Geirsson A, Bothwell AL, Hammond GL. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes. The Journal Of Heart And Lung Transplantation 2004, 23: 1077-1081. PMID: 15454174, DOI: 10.1016/j.healun.2004.07.020.Peer-Reviewed Original ResearchConceptsClass II expressionCIITA promoter IIIPromoter IIIMajor histocompatibilityClass II transactivator promoter IIIMajor histocompatibility class II expressionMHC class II expressionConstitutive class II expressionClass II transcriptsAllograft toleranceLymphocyte proliferationT lymphocytesAllogenic responseLymphocyte stimulationMurine B lymphocytesB cellsB lymphocytesClass IIFlow cytometryFunctional affectsConcurrent suppressionBp 152AlloresponseSignificant suppressionCIITA promoter
2003
Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA1
Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA1. Transplantation 2003, 76: 387-394. PMID: 12883198, DOI: 10.1097/01.tp.0000073612.04525.46.Peer-Reviewed Original ResearchMeSH KeywordsBase SequenceDNA MethylationDNA, ComplementaryHeLa CellsHumansLuciferasesMajor Histocompatibility ComplexMolecular Sequence DataNuclear ProteinsNucleic Acid ConformationPromoter Regions, GeneticProtein Structure, TertiaryRNA, UntranslatedSuppression, GeneticTrans-ActivatorsTranscription, GeneticTransfectionTrophoblastsConceptsClass II expressionMHC class IICIITA promoter IVPromoter IVQuantitative polymerase chain reactionMajor histocompatibility complexAllograft tolerancePolymerase chain reactionFluorescence-activated cell sortingCIITA expressionHuman leukocyte antigen-DRClass IIMHC class II expressionClassic major histocompatibility complexChain reactionCell sortingPurposes of transplantationLack expressionHistocompatibility complexNoncoding RNAsII-deficient cellsSelective suppressionPromoter-reporter constructsCIITA promoterInhibitory domain
1998
Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
Collinge M, Pardi R, Bender J. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. The Journal Of Immunology 1998, 161: 1589-93. PMID: 9712019, DOI: 10.4049/jimmunol.161.4.1589.Peer-Reviewed Original ResearchConceptsClass II transactivatorNK cellsIFN-gamma-dependent mechanismIFN-gamma-independent mannerLymphocyte adhesionMHC class II expressionHLA-DR alpha mRNAHLA-DR expressionMHC class II moleculesNK cell activationAllogeneic endothelial cellsClass II expressionIFN-gamma-induced MHC class II expressionClass II moleculesAlpha mRNA expressionCell linesHLA-DRIFN-gammaCell activationMRNA expressionEndothelial cellsAlpha mRNACellsPromoter constructsActivation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply